Skip to main content
. 2020 May 28;17:100300. doi: 10.1016/j.mtchem.2020.100300

Table 3.

Clinical trials of vaccines to date against COVID-19 [[91], [92], [93], [94]].

Country Vaccine Phase
China Ad5-nCoV II
China Unnamed (Inactivated SARS-CoV-2 virus) I-II
China Covid-19/aAPC I
China LV-SMENP-DC I
China Unnamed (inactivated COVID-19 virus) II
USA mRNA-1273 I
USA/S. Korea INO-4800 I-II
USA/Germany BNT162 I-II
UK ChAdOx1 nCoV-19 I-II
Canada bacTRL-Spike I